<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Rachagani S</submitter><funding>NCI NIH HHS</funding><pagination>40295-309</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4741896</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6(37)</volume><pubmed_abstract>Differential expression of microRNAs (miRNAs) has been demonstrated in various cancers, including pancreatic cancer (PC). Due to the lack of tissue samples from early-stages of PC, the stage-specific alteration of miRNAs during PC initiation and progression is largely unknown. In this study, we investigated the global miRNA expression profile and their processing machinery during PC progression using the KrasG12D;Pdx1-Cre (KC) mouse model. At 25 weeks, the miRNA microarray analysis revealed significant downregulation of miR-150, miR-494, miR-138, miR-148a, miR-216a, and miR-217 and upregulation of miR-146b, miR-205, miR-31, miR-192, and miR-21 in KC mice compared to controls. Further, expression of miRNA biosynthetic machinery including Dicer, Exportin-5, TRKRA, and TARBP2 were downregulat</pubmed_abstract><journal>Oncotarget</journal><pubmed_title>Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.</pubmed_title><pmcid>PMC4741896</pmcid><funding_grant_id>U01 CA111294</funding_grant_id><funding_grant_id>CA127297</funding_grant_id><funding_grant_id>U54 CA163120</funding_grant_id><funding_grant_id>UO1 CA111294</funding_grant_id><funding_grant_id>P50 CA127297</funding_grant_id><pubmed_authors>Macha MA</pubmed_authors><pubmed_authors>Menning MS</pubmed_authors><pubmed_authors>Rachagani S</pubmed_authors><pubmed_authors>Dey P</pubmed_authors><pubmed_authors>Smith LM</pubmed_authors><pubmed_authors>Batra SK</pubmed_authors><pubmed_authors>Pai P</pubmed_authors><pubmed_authors>Mo YY</pubmed_authors></additional><is_claimable>false</is_claimable><name>Changes in microRNA (miRNA) expression during pancreatic cancer development and progression in a genetically engineered KrasG12D;Pdx1-Cre mouse (KC) model.</name><description>Differential expression of microRNAs (miRNAs) has been demonstrated in various cancers, including pancreatic cancer (PC). Due to the lack of tissue samples from early-stages of PC, the stage-specific alteration of miRNAs during PC initiation and progression is largely unknown. In this study, we investigated the global miRNA expression profile and their processing machinery during PC progression using the KrasG12D;Pdx1-Cre (KC) mouse model. At 25 weeks, the miRNA microarray analysis revealed significant downregulation of miR-150, miR-494, miR-138, miR-148a, miR-216a, and miR-217 and upregulation of miR-146b, miR-205, miR-31, miR-192, and miR-21 in KC mice compared to controls. Further, expression of miRNA biosynthetic machinery including Dicer, Exportin-5, TRKRA, and TARBP2 were downregulat</description><dates><release>2015-01-01T00:00:00Z</release><publication>2015 Nov</publication><modification>2026-05-05T12:00:53.687Z</modification><creation>2026-04-07T21:44:09.016Z</creation></dates><accession>S-EPMC4741896</accession><cross_references><pubmed>26516699</pubmed><doi>10.18632/oncotarget.5641</doi></cross_references></HashMap>